Home  Products Search  Properties Search  中文版
Home > Dictionary > Information
K value of petroleum hydrocarbons;characterization factor of petroleum hydrocarbons
Molecular formula :
CAS :

nature : also known as the K value of petroleum hydrocarbons (K value of petroleum hydrocarbons), the characterization of hydrocarbons and petroleum distillates chemical composition of a target. The factor is usually proportional to the average boiling point, and inversely proportional to the relative density. An average boiling point of the earliest molecular average boiling point, after the switch to the boiling point average cube root. Right distillate oil, the higher the value of K, the greater the corresponding saturation. Characteristics of factors to evaluate petroleum distillate very few important features for guiding oil processing, process design has a certain value.


Notice:Each item can have many explanations from different angels. If you want grasp the item comprehensively,please see below "more details data".
Structure:
Please see below "More Detailed Data"
More Detailed Data:
1) K-value
2) petroleum
3) petroleum
4) hydrocarbon
5) hydrocarbon
6) Carbon
7) gasoline;petrol
8) carbon
9) Activated carbon;Activated charcoal;Carbon
10) Carbon;Activated carbon;acticarbone;activated charcoal;adsorbit;ag 3 (adsorbent);ag 5;ag 5 (adsorbent);ak (adsorbent);amoco px 21;anthrasorb
Notice Some description was translated by software and the data is only as a reference.
Patent:
1) 2 methyl-thieno-benzodiazepine lyophilizde formulation
2) Pharmaceutical combination comprising either (S)-20ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl] propanoic acid
3) Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method
4) Drugs for ameliorating postcibal hyperglycaemia
5) Composition for prevention and treatment of influenza having antivirus effect
6) Use of long pentraxin PTX3 for treatment of FGF-3 mediated tumour diseases
7) Nuclec acid adjuvants
8) HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases
9) Stable liquid formulations of antibodies
10) Remedies for psychoneurosis